Emily M. Leproust - 19 Dec 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Executive Officer, Director
Signature
/s/ Alyssa Zhang, as Attorney-in-Fact for Emily M. Leproust
Issuer symbol
TWST
Transactions as of
19 Dec 2022
Net transactions value
$0
Form type
4
Filing time
21 Dec 2022, 15:57:28 UTC
Previous filing
22 Nov 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +59,758 +33% $0.000000 239,707 19 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TWST Employee Stock Option (right to buy) 24,360 19 Dec 2022 Common Stock 0 $5.95 Direct F2
holding TWST Employee Stock Option (right to buy) 150,879 19 Dec 2022 Common Stock 0 $8.82 Direct F3
holding TWST Employee Stock Option (right to buy) 266,539 19 Dec 2022 Common Stock 0 $26.66 Direct F4
holding TWST Employee Stock Option (right to buy) 131,290 19 Dec 2022 Common Stock 0 $23.33 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of December 19, 2022 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.
F2 The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F3 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F4 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F5 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.